All questions
Specific populations: Skyrizi (risankizumab-rzaa) in plaque psoriasis
2 questions · 1 source
Specific populations questions that apply to every indication of Skyrizi are on Skyrizi (risankizumab-rzaa), all indications: Specific populations.
Pediatric use
Is Skyrizi approved for children with plaque psoriasis?
Applies to Pediatric patients 6 years of age and older with moderate-to-severe plaque psoriasis
How well does Skyrizi work in children aged 12 and older with plaque psoriasis?
Applies to Pediatric patients 6 years of age and older with moderate-to-severe plaque psoriasis
Note: Table 11 reports the SKYRIZI arm (N=54) only, as n (%); the label does not give the ustekinumab arm results.